BO HUI BIOTECH CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
BO HUI BIOTECH CO., LTD. primarily operates in two core business areas:
1. Cancer Immunotherapy: Exclusively introducing the HITV (Human Initiated Therapeutic Vaccine) immunotherapy from Hasumi, Japan, which fights cancer by activating the patient's own autologous immune cells. This therapy has been approved by the Ministry of Health and Welfare to treat patients with stage IV solid tumors, including lung cancer, breast cancer, renal cell carcinoma, gastric cancer, colorectal cancer, and head and neck cancer, offering the advantage of lower side effects compared to conventional chemotherapy.
2. Biotech Cosmetics R&D: Pioneering the development of dual-exosome technology, which combines the advantages of both animal and plant exosomes to bring breakthrough innovations to the cosmetics industry. This technology delivers highly effective and diverse skincare benefits, deeply nourishing and repairing the skin. The company's scope of services covers the research, development, and wholesale of skincare products, creams, serums, collagen, and other related products.
In addition, BO HUI BIOTECH CO., LTD. also provides comprehensive business services, including medical management consulting, biotechnology services, research and development services, and international trade.
1. Cancer Immunotherapy: Exclusively introducing the HITV (Human Initiated Therapeutic Vaccine) immunotherapy from Hasumi, Japan, which fights cancer by activating the patient's own autologous immune cells. This therapy has been approved by the Ministry of Health and Welfare to treat patients with stage IV solid tumors, including lung cancer, breast cancer, renal cell carcinoma, gastric cancer, colorectal cancer, and head and neck cancer, offering the advantage of lower side effects compared to conventional chemotherapy.
2. Biotech Cosmetics R&D: Pioneering the development of dual-exosome technology, which combines the advantages of both animal and plant exosomes to bring breakthrough innovations to the cosmetics industry. This technology delivers highly effective and diverse skincare benefits, deeply nourishing and repairing the skin. The company's scope of services covers the research, development, and wholesale of skincare products, creams, serums, collagen, and other related products.
In addition, BO HUI BIOTECH CO., LTD. also provides comprehensive business services, including medical management consulting, biotechnology services, research and development services, and international trade.
The content above was translated by Ai
Founded Year
2018
Unified Business No.
69440475
Status
Active
Number of Employees
27
Total Paid-in
Capital
800,000,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BO HUI BIOTECH CO., LTD. focuses on cancer immune cell therapy technology and biotech cosmetics research and development, and is the first biotechnology company in Taiwan to obtain the exclusive technology license for Japan's Hasumi HITV immunotherapy, dedicated to introducing advanced cell therapy technologies into Taiwan. In August 2021, the company obtained approval from the Ministry of Health and Welfare for the "Autologous Immune Cell (DC-CIK) Therapy for Stage IV Solid Tumors" under the Special Regulations program, collaborating with Kuang Tien General Hospital to provide innovative treatment options for cancer patients in Taiwan. BO HUI BIOTECH CO., LTD. possesses a GTP laboratory that has passed inspection by the Taiwan Food and Drug Administration of the Ministry of Health and Welfare, and continues to upgrade toward comprehensive GMP standards, demonstrating its professional strength and quality assurance in the field of cell therapy.
The content above was translated by Ai
